RVMD

top-performing-healthcare-stocks-in-the-past-month

Biotechnology DXCM ELAN FHLC FXH GH GILD IHI ILMN IXJ IYH MRNA PEN RVMD RVTY TECH Uncategorized VHT XLV

Top performing healthcare stocks in the past month

Jan 28, 2026

Comment (1) iQoncept/iStock via Getty Images As the first month of 2026 comes to an...

Biotechnology MRK RVMD Uncategorized

Revolution Medicines plummets on report Merck walks from acquisition talks

Jan 26, 2026

disc-medicine-and-sanofi-reportedly-face-delays-for-fda-national-priority-review-vouchers

ACHV Biotechnology GCVRZ IRON LLY RVMD SAN:CA SNY SNYNF Uncategorized

Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers

Jan 15, 2026

Comments Grandbrothers/iStock Editorial via Getty Images Two drugs developed by Disc Medicine (IRON) and Sanofi...

revolution-medicines-declines-to-comment-on-m&a-speculation-at-conference

Biotechnology MRK RVMD Uncategorized

Revolution Medicines declines to comment on M&A speculation at conference

Jan 12, 2026

M&A Comments Revolution Medicines (RVMD) declined to comment on recent M&A speculation at the JPMorgan...

merck-in-talks-to-acquire-revolution-medicines-for-about-$30b-–-wsj

ABBV Biotechnology MRK RVMD Uncategorized

Merck in talks to acquire Revolution Medicines for about $30B – WSJ

Jan 9, 2026

On the Move M&A Comments (18) Marko Georgiev/Getty Images News Merck (MRK) is in talks...

ABBV Biotechnology MRK RVMD Uncategorized

Revolution Medicines soars on report Merck in talks to buy (update)

Jan 8, 2026

Biotechnology RVMD Uncategorized

Revolution Medicines gains Breakthrough Therapy status for zoldonrasib

Jan 8, 2026

Biotechnology IMRX RVMD Uncategorized VSTM

Immuneering plummets following phase 2 data of atebimetinib for pancreatic cancer

Jan 7, 2026

ABBV Biotechnology RVMD Uncategorized

AbbVie says not in talks to buy Revolution Medicines

Jan 7, 2026

ABBV Biotechnology ERAS RVMD Uncategorized

Revolution Medicines jumps on report AbbVie nears takeover

Jan 7, 2026

Next Page »